Journal article
An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).
Authors
Moulton C; Levine MN; Law C; Hart R; Ruo L; Gu C; Hendler A; Gulenchyn KY; Haider MA; Marcaccio M
Journal
Journal of Clinical Oncology, Vol. 29, No. 15_suppl, pp. 3520–3520
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.3520
ISSN
0732-183X